Atara, Pierre Fabre's cell therapy to get another shot at FDA approval

May 7, 2026 09:17 AM EDTUpdated 10:46 AM Cell/Gene TxFDA+ Atara, Pierre Fab­re will get an­oth­er shot at FDA ap­proval, a week af­ter Prasad's de­par­ture Max Gelman Senior Editor There’s new life for a twice-re­ject­ed T cell ther­a­py from Atara Bio­ther­a­peu­tics and Pierre Fab­re Phar­ma­ceu­ti­cals. US reg­u­la­tors are will­ing to re­con­sid­er us­ing a Phase … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER